NeuroPace (NPCE) Non Operating Interest Expenses (2020 - 2026)

NeuroPace has reported Non Operating Interest Expenses for 7 years, with the latest figure at $1.5 million in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 25.25% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $6.3 million, a 26.57% decrease from a year earlier, with the FY2025 full-year figure at $7.5 million, down 15.24% from the prior year.
• Non Operating Interest Expenses was $1.5 million for Q2 2026 at NeuroPace, up from $1.5 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $2.3 million in Q1 2024, with the low at $1.5 million in Q1 2026.
• Average Non Operating Interest Expenses over 5 years is $2.0 million, with a median of $2.0 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Non Operating Interest Expenses climbed 15.2% in 2023, then fell 29.35% in 2026.
• Over 5 years, Non Operating Interest Expenses stood at $1.9 million in 2022, then gained by 15.2% to $2.2 million in 2023, then slipped by 1.97% to $2.2 million in 2024, then dropped by 27.01% to $1.6 million in 2025, then decreased by 3.81% to $1.5 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $1.5 million (Q2 2026), $1.5 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.